Page 235 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 235
YI P0665 HBV VARIANTS PRESENT IN TREATMENT NAÏVE PATIENTS ePOSTERS
YI P0666 CAN PREDICT RESPONSE TO NA THERAPY IN IMMUNE
YI P0667 CLEARANCE DISEASE
YI P0668 Julianne Bayliss*, Gillian Rosenberg, Alexander Thompson, Anuj Gaggar,
YI P0669 Kathryn Kitrinos, Mani Subramanian, Patrick Marcellin, Edward Gane,
YI P0670 Henry L. Chan, Xin Li, Danni Colledge, Lilly Yuen, Margaret Littlejohn,
Rosalind Edwards, Kathleen Jackson, Sara Bonanzinga,
Rachel Hammond, Scott Bowden, Stephen Locarnini, Peter Revill, Australia
ANALYZING THE MUTATION PATTERN OF MULTI-DRUG
RESISTANT HEPATITIS B VIRUS DURING ENTECAVIR
RESCUE THERAPY
Bora Jin*,Young Eun Chon, Beom Kyung Kim, Seung Up Kim,
Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Seungtaek Kim,
Sang Hoon Ahn, South Korea
INTERRUPTION OF NUCLEOS(T)IDE ANALOGUE THERAPY
FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B – A NEW
CONCEPT TO ACHIEVE HBSAG DECLINE?
Christoph Hoener Zu Siederdissen*, Franziska Rinker, Christine Falk,
Natalie Filmann, Benjamin Maasoumy, Katja Deterding, Kerstin Port,
Carola Mix, Eva Herrmann, Heiner Wedemeyer, Michael P. Manns,
Anke Kraft, Markus Cornberg, Germany
ON-TREATMENT HBSAG KINETICS TO PREDICT LONG-
TERM HDV RNA RESPONSE TO PEG-IFNA TREATMENT OF
HEPATITIS DELTA
Michael Wöbse*, Svenja Hardtke, Stefanie Ernst, Heidrich Benjamin,
Birgit Bremer, Onur Keskin, Armin Koch, Michael P. Manns,
Heiner Wedemeyer, Cihan Yurdaydin, Germany
CONSOLIDATION THERAPY WITH ENTECAVIR CAN
PREVENT POST-TREATMENT HBSAG REBOUND IN
HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS
TREATED WITH PEGINTERFERON ALPHA
Willem Pieter Brouwer*, Milan J. Sonneveld, Qing Xie, Ningping Zhang,
Stefan Zeuzem, Fehmi Tabak, Qin Zhang, Krzysztof Simon, Ulus S. Akarca,
Adrian Streinu-Cercel, Bettina Hansen, Harry L. Janssen, The Netherlands
PLASMA MICRORNA LEVELS ARE ASSOCIATED WITH
THERAPY RESPONSE IN CHRONIC HEPATITIS B PATIENTS
TREATED WITH PEGINTERFERON AND ADEFOVIR
Meike Van Der Ree*, Louis Jansen, Karel van Dort, Bart Takkenberg,
Neeltje A. Kootstra, Hendrik W. Reesink, The Netherlands
Vienna, Austria • April 22–26, 2015 235
YI P0666 CAN PREDICT RESPONSE TO NA THERAPY IN IMMUNE
YI P0667 CLEARANCE DISEASE
YI P0668 Julianne Bayliss*, Gillian Rosenberg, Alexander Thompson, Anuj Gaggar,
YI P0669 Kathryn Kitrinos, Mani Subramanian, Patrick Marcellin, Edward Gane,
YI P0670 Henry L. Chan, Xin Li, Danni Colledge, Lilly Yuen, Margaret Littlejohn,
Rosalind Edwards, Kathleen Jackson, Sara Bonanzinga,
Rachel Hammond, Scott Bowden, Stephen Locarnini, Peter Revill, Australia
ANALYZING THE MUTATION PATTERN OF MULTI-DRUG
RESISTANT HEPATITIS B VIRUS DURING ENTECAVIR
RESCUE THERAPY
Bora Jin*,Young Eun Chon, Beom Kyung Kim, Seung Up Kim,
Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Seungtaek Kim,
Sang Hoon Ahn, South Korea
INTERRUPTION OF NUCLEOS(T)IDE ANALOGUE THERAPY
FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B – A NEW
CONCEPT TO ACHIEVE HBSAG DECLINE?
Christoph Hoener Zu Siederdissen*, Franziska Rinker, Christine Falk,
Natalie Filmann, Benjamin Maasoumy, Katja Deterding, Kerstin Port,
Carola Mix, Eva Herrmann, Heiner Wedemeyer, Michael P. Manns,
Anke Kraft, Markus Cornberg, Germany
ON-TREATMENT HBSAG KINETICS TO PREDICT LONG-
TERM HDV RNA RESPONSE TO PEG-IFNA TREATMENT OF
HEPATITIS DELTA
Michael Wöbse*, Svenja Hardtke, Stefanie Ernst, Heidrich Benjamin,
Birgit Bremer, Onur Keskin, Armin Koch, Michael P. Manns,
Heiner Wedemeyer, Cihan Yurdaydin, Germany
CONSOLIDATION THERAPY WITH ENTECAVIR CAN
PREVENT POST-TREATMENT HBSAG REBOUND IN
HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS
TREATED WITH PEGINTERFERON ALPHA
Willem Pieter Brouwer*, Milan J. Sonneveld, Qing Xie, Ningping Zhang,
Stefan Zeuzem, Fehmi Tabak, Qin Zhang, Krzysztof Simon, Ulus S. Akarca,
Adrian Streinu-Cercel, Bettina Hansen, Harry L. Janssen, The Netherlands
PLASMA MICRORNA LEVELS ARE ASSOCIATED WITH
THERAPY RESPONSE IN CHRONIC HEPATITIS B PATIENTS
TREATED WITH PEGINTERFERON AND ADEFOVIR
Meike Van Der Ree*, Louis Jansen, Karel van Dort, Bart Takkenberg,
Neeltje A. Kootstra, Hendrik W. Reesink, The Netherlands
Vienna, Austria • April 22–26, 2015 235
